Article

Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis

Rheumatology A department, Paris Descartes University, Cochin Hospital, APHP, Sorbonne Paris Cité, Paris, France.
Annals of the rheumatic diseases (Impact Factor: 9.27). 11/2011; 71(3):394-9. DOI: 10.1136/annrheumdis-2011-200143
Source: PubMed

ABSTRACT To evaluate the possible merit of endothelial markers for the prediction of ischaemic digital ulcers in patients with systemic sclerosis (SSc).
Circulating endothelial progenitor cells (EPC), circulating endothelial cells and serum levels of placental growth factor (PlGF), soluble vascular adhesion molecule and vascular endothelial growth factor were measured in a prospective cohort of 100 SSc patients. The primary outcome was the occurrence of one or more new ischaemic digital ulcers during a planned 3-year follow-up.
After the follow-up period, 17 patients developed new digital ulcers. By multivariate analysis focused on biomarkers, high PlGF serum levels and low EPC counts were identified as predictors of the occurrence of at least one new digital ulcer. In a secondary model including biomarkers together with clinical SSc characteristics all predictors of digital ulcers defined by p≤0.1 in univariate analysis, high PlGF serum levels (HR 7.26, 95% CI 1.92 to 27.41) and a history of digital ulcers (HR 9.32, 95% CI 1.51 to 59.83) were identified as independent predictors of a new digital ulcer. In an alternative model excluding patients with a history of digital ulcers at baseline, high PlGF serum levels (HR 13.46, 95% CI 1.58 to 114.73) and low EPC counts (HR 7.95, 95% CI 2.09 to 30.09) remained predictive of new digital ulcer occurrence during follow-up.
This study identified high PlGF serum levels and low circulating EPC counts as predictors of new digital ulcers in SSc. It highlights the critical role of angiogenesis in this vascular outcome. These markers may improve digital ulcer risk stratification and therefore allow earlier therapeutic intervention.

Full-text

Available from: Georges Uzan, May 29, 2014
0 Followers
 · 
110 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective To clarify the role of pentraxin 3 (PTX3), a multifunctional pattern recognition protein that can suppress fibroblast growth factor 2 (FGF-2), in systemic sclerosis (SSc)-related vasculopathy.Methods We assessed 171 SSc patients and 19 age- and sex-matched healthy control subjects. Circulating PTX3 and FGF-2 levels were measured by enzyme immunoassay, and CD34+CD133+CD309+ endothelial progenitor cells (EPCs) were counted by flow cytometry. Correlations between PTX3 and FGF-2 and the presence or future development of vascular manifestations, including digital ulcers and pulmonary arterial hypertension (PAH), were identified by univariate and multivariate analysis. The effect of PTX3 on EPC differentiation was evaluated in proangiogenic cultures of mouse bone marrow cells in combination with colony formation assay.ResultsCirculating PTX3 and FGF-2 levels were significantly higher in SSc patients than in healthy control subjects. PTX3 was elevated in SSc patients who had digital ulcers or PAH, while FGF-2 was reduced in SSc patients with PAH. Multivariate analysis identified elevated PTX3 as an independent parameter associated with the presence of digital ulcers and PAH, and PTX3 levels were a useful predictor of future occurrences of digital ulcers. Reduced FGF-2 was independently associated with the presence of PAH. EPC counts were significantly lower in patients with digital ulcers or PAH and correlated negatively with circulating PTX3 concentrations. Finally, PTX3 inhibited EPC differentiation in vitro.Conclusion In SSc patients, exposure to high concentrations of PTX3 may suppress EPC-mediated vasculogenesis and promote vascular manifestations such as digital ulcers and PAH.
    11/2014; 67(2). DOI:10.1002/art.38953
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective. Patients with SSc are at high risk for the development of ischaemic digital ulcers (DUs), which occur in 35% to 60% of SSc patients. The aim of this study was to asses in SSc patients a correlation between intrarenal arterial stiffness and DUs and to evaluate the prognostic value of Doppler indices to predict the new DUs occurrence. Methods. Seventy (58 female and 12 male; mean age 49,5±13,8 years) unselected, consecutive patients with SSc were enrolled. In all patient Doppler ultrasound examination was performed. The following Doppler indices of intrarenal stiffness were measured: peak systolic velocity (PSV), end diastolic velocity (EDV), resistive index (RI), pulsatile index (PI), systolic/diastolic ratio (S/D). Results. 30 of 70 patients (42%) experienced new DUs. RI, S/D and PI are significantly higher in SSc patient with new DUs than in SSc patients without new DUs. The receiver operating characteristic (ROC) curves demonstrated a good accuracy of new DUs prediction for RI (0,94, p<0,0001), S/D (0,92, p<0,0001), PI (0,88, p<0,0001). Conversely, the ROC curve showed no performance for PSV (0,58, p>0,05) and EDV (0,28, p>0,05). Using this cut-off value of 0,70 for RI and 3,25 for S/D the positive predictive value was 90,6% and 92,9%, respectively. Conclusions. We can conclude that Doppler indices of intrarenal stiffness are reliable markers of new DU occurrence. Doppler indices could be used in association to the capillaroscopic and clinical findings or serological tests for the identification of patients at high risk of developing DUs. © 2014 American College of Rheumatology.
    09/2014; 66(9). DOI:10.1002/acr.22309
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: OBJECTIVE: To investigate whether women with systemic sclerosis (SSc) have increased risk of osteoporosis (OP) and related fractures compared to a "high risk" population with rheumatoid arthritis (RA) and also healthy controls and determine putative specific OP and fracture risk factors. PATIENTS AND METHODS: Cross-sectional study with successive inclusion of age-matched healthy, SSc, and RA women. Risk factors for OP and fracture were collected for all patients. Bone mineral density (BMD) was systematically measured at lumbar spine and total hip region with DXA. RESULTS: We included 71 SSc, 139 RA and 227 healthy women. The prevalence of OP and fracture was similar in SSc and RA, and was for both higher than in healthy controls (OP: 30% in SSc, 32% in RA and 11% in controls; fracture: 35% in SSc, 33% in RA and 10% in controls). Multivariate analysis identified age as a risk factor of OP in SSc. Age and low 25(OH)D levels were recognized as risk factors of fracture in SSc. In comparison, age and corticosteroid treatment were associated with OP in RA. Multivariate analysis confirmed age, OP and low 25(OH)D levels as independent risk factors of fractures in RA. CONCLUSION: The prevalence of OP and fracture in SSc was increased compared to healthy women and reached the high prevalence associated with RA. Age and vitamin D deficiency were identified as risk factors of fracture in SSc. Thus, increasing the awareness and performance of BMD measurements together with vitamin D supply in patients with SSc is warranted.
    12/2012; 64(12). DOI:10.1002/acr.21761